Premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) are prevalent among adolescents and young adults worldwide and can substantially impair emotional well-being, daily functioning, and family life. This review summarizes current definitions of premenstrual disorders (PMDs); examines validated retrospective and prospective diagnostic tools; and reviews epidemiology, pathophysiology, and both pharmacologic and nonpharmacologic management strategies. It also highlights clinical strategies to improve recognition, patient and family education, and advocacy to reduce stigma and advance care.
Rome et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: